Peptide-biphenyl hybrid-capped AuNPs: stability and biocompatibility under cell culture conditions
© Connolly et al.; licensee Springer. 2013
Received: 9 April 2013
Accepted: 27 June 2013
Published: 6 July 2013
In this study, we explored the biocompatibility of Au nanoparticles (NPs) capped with peptide-biphenyl hybrid (PBH) ligands containing glycine (Gly), cysteine (Cys), tyrosine (Tyr), tryptophan (Trp) and methionine (Met) amino acids in the human hepatocellular carcinoma cell line Hep G2. Five AuNPs, Au[(Gly-Tyr-Met)2B], Au[(Gly-Trp-Met)2B], Au[(Met)2B], Au[(Gly-Tyr-TrCys)2B] and Au[(TrCys)2B], were synthesised. Physico-chemical and cytotoxic properties were thoroughly studied. Transmission electron micrographs showed isolated near-spherical nanoparticles with diameters of 1.5, 1.6, 2.3, 1.8 and 2.3 nm, respectively. Dynamic light scattering evidenced the high stability of suspensions in Milli-Q water and culture medium, particularly when supplemented with serum, showing in all cases a tendency to form agglomerates with diameters approximately 200 nm. In the cytotoxicity studies, interference caused by AuNPs with some typical cytotoxicity assays was demonstrated; thus, only data obtained from the resazurin based assay were used. After 48-h incubation, only concentrations ≥50 μg/ml exhibited cytotoxicity. Such doses were also responsible for an increase in reactive oxygen species (ROS). Some differences were observed among the studied NPs. Of particular importance is the AuNPs capped with the PBH ligand (Gly-Tyr-TrCys)2B showing remarkable stability in culture medium, even in the absence of serum. Moreover, these AuNPs have unique biological effects on Hep G2 cells while showing low toxicity. The production of ROS along with supporting optical microscopy images suggests cellular interaction/uptake of these particular AuNPs. Future research efforts should further test this hypothesis, as such interaction/uptake is highly relevant in drug delivery systems.
KeywordsGold nanoparticles Hep G2 ROS Autophagy Cytotoxicity
At the forefront of many lines of research in drug delivery are the endless possibilities of gold nanoparticles (AuNPs) [1–4]. These molecules are readily taken up by cells, and they therefore provide a valuable means for drug delivery, with reports of efficient transport across the blood–brain barrier in mice  and nuclear penetration in the human HeLa cell line . At nanoscale, the properties conferred upon such an otherwise inert metal in its bulk form are surprising. It is precisely these unique properties that offer potential in fields as diverse as diagnostics, anti-cancer therapies, catalysts and fuel cells. One avenue that has been studied exhaustively in recent years is the use of coatings and capping agents in the rational design of NPs, both to stabilise and functionalise these nanoparticles. Specific capping agents can lead to the self-assembly of NPs into ordered ‘superstructures’ creating different shapes , and by altering the capping structure, different arrangements can be achieved. In terms of biocompatibility, when using a polyvinyl alcohol capping agent, AuNPs do not show toxicity in zebrafish, despite being taken up into embryos and evidence of bioaccumulation . These observations highlight the use of capping agents as an approach to achieve safer NPs. We recently proposed the use of peptide-biphenyl hybrid (PBH) ligands as capping agents . PBHs have a biphenyl system and two amino acid/peptide fragments, and they present key characteristics, such as dynamic properties in solution , ordered structures in the solid phase  and biological activity as calpain inhibitors . Some of these properties arise from the presence of amino acid residues, as well as aromatic rings, that are able to participate in a variety of non-covalent bonds, including hydrogen bonds [13, 14] and arene interactions [15, 16]. In addition, the conformational flexibility around the aryl-aryl single bond allows the PBH to adopt its structure in order to obtain the most favourable interactions with other chemical species, thus achieving high biological activity . In peptidomimetics, this approach is considered a novel way to tailor NPs to have desired physico-chemical properties, which could contribute, for example, to advances in biomedical applications for AuNPs as drug delivery systems. A molecule can be designed in such a way as to benefit from structure-activity relationships and to attain higher levels of stability and/or biocompatibility. In a study on the design of peptide capping ligands for AuNPs, Lévy et al.  reported that peptide chain length, hydrophobicity and charge strongly influence NP stability. Here, we capped AuNPs with various PBH ligands and studied how the ligand structures influence the stability and the physico-chemical properties of the AuNPs under cell culture conditions and how they affect the biological response.
The huge discrepancies in reports on NP toxicity may be related to their different stabilities under various experimental conditions, leading to distinct physico-chemical properties that directly influence the effect of these particles. Given the unique and unpredictable behaviour of NPs in different environments [19, 20], we performed a detailed physico-chemical analysis, a prerequisite for any NP toxicity study. Distinct NP properties, such as size, shape, aggregation state, zeta potential and dispersibility, along with the inherent composition of the NPs themselves, all influence the degree of toxicity [21–23]. To study the interaction between these PBH-capped AuNPs and biological systems, we undertook cytotoxicity studies. Many articles have demonstrated a close relationship between size and toxicity for AuNPs [24, 25]. Findings suggest that size not only can influence uptake but may also dictate the possible interaction with DNA grooves [26, 27], thus leading to AuNPs of different sizes showing distinct mechanisms of toxicity. For instance, AuNPs of 1.4 and 1.2 nm in diameter, thus differing by only 0.2 nm, show different pathways of toxicity in HeLa human cervix carcinoma cell lines, causing cell death by necrosis and apoptosis, respectively . AuNPs have reported LC50 values of 65 to 75 μg/ml in Daphnia magna. According to Farkas et al. , these particles are potent inducers of reactive oxygen species (ROS) in rainbow trout hepatocytes, with concentrations of 17.4 μg/ml increasing ROS production threefold as early as 2 h post-exposure. However, there have also been reports of AuNP biocompatibility, suggesting cell-selective responses following AuNP exposure that may be related to specific mechanisms of toxicity. Cell death through apoptosis has been reported in the human lung carcinoma cell line A549 after exposure to AuNPs, with no evidence of cytotoxicity in BHK21 (baby hamster kidney), Hep G2 (human hepatocellular liver carcinoma) or MDCK (canine epithelial kidney) cell lines [31, 32]. These observations may be explained by AuNP interaction with cellular stress response mechanisms on a genetic level , which may dictate the cells capacity to prevent cytotoxic effects.
To further our understanding of AuNP interaction with biological systems and the properties that may govern biocompatibility, after performing a detailed physico-chemical characterisation of all the PBH-capped AuNPs, we used an in vitro approach to assess the possible toxic effects and the oxidative stress potential of these particles. We focused on how the structure of the capping PBH used affects NP size and stability over time under a range of conditions in vitro. Differences in NP behaviour when suspended in cell culture medium with serum and without serum were examined. This approach allowed us to compare any changes in the physico-chemical properties of the NPs that may be associated with the interaction of the agent with fetal bovine serum and protein coating. Given that the liver is one of the main sites of AuNP bioaccumulation following intravenous injection [34, 35]; we chose a human hepatocellular carcinoma cell line (Hep G2) as the most appropriate and relevant test system. NPs have been described to interfere with assays, and some reviews report the limitations of certain assay systems  and that AuNPs even have the capacity to quench or enhance fluorescence depending on the plasmon field and dipole energy . Also, gold can bind biological thiols such as glutathione [38, 39]. Therefore, in this study, close attention was paid to any potential interference of AuNPs with the assay systems.
Chemicals and reagents
The synthesis and characterisation of PBHs are described in detail in Additional file 1. The chemicals used for AuNP synthesis, such as hydrogen tetrachloroaurate (III) trihydrate (HAuCl4∙3H2O), sodium borohydride (NaBH4), ethanol, 2-propanol and dimethyl sulfoxide-d 6 were purchased from Sigma-Aldrich (Madrid, Spain).
For biocompatibility studies, Eagle’s minimum essential medium (EMEM), ultra glutamine 1 (200 mM in 0.85% NaCl solution), non-essential amino acids 100 X (NEAA), fetal bovine serum (FBS), penicillin/streptomycin (10,000 U/ml/10 mg/ml) and trypsin EDTA (200 mg/l EDTA, 17,000 U trypsin/l) were all sourced from LONZA (Barcelona, Spain). MEM and EMEM without phenol red were purchased from PAN Biotech GmbH (Aidenbach, Germany). High-grade purity water (>18 MΩ cm) obtained from a Milli-Q Element A10 Century (Millipore Iberia, Madrid, Spain) was used in all the experiments. All other chemicals were purchased from Sigma-Aldrich.
Synthesis of AuNPs
Physico-chemical characterisation of AuNPs
Transmission electron microscopy
Transmission electron microscopy (TEM) images of the synthesised AuNPs were obtained using a Philips Tecnai 20 operating at 200 kV (FEI, Eindhoven, The Netherlands). AuNPs were also examined after their suspension in culture medium without serum (EMEM/S-) at time 0 and 24 h using a LEO-910 microscope (Carl Zeiss, Oberkochen, Germany) operating at an accelerating voltage of 80 kV and equipped with a digital camera Gatan Bioscan 792 (Gatan Inc., Pleasanton, CA, USA). The samples for TEM characterisation were prepared by placing and evaporating a drop of the AuNPs in 2-propanol, or in medium, on carbon-coated copper grids (200 mesh). Average particle sizes were obtained by measuring the diameters of 150 particles.
Nuclear magnetic resonance
1H nuclear magnetic resonance (NMR) and 13C NMR spectra were recorded on Varian Mercury-400 and Varian Inova-300 instruments (Agilent Tecnologies, Santa Clara, CA, USA). Chemical shift (δ) constants are indicated in hertz. 1H NMR spectra were referenced to the chemical shift of TMS (δ = 0.00 ppm). 13C NMR spectra were referenced to the chemical shift of the deuterated solvent. The following abbreviations are used to explain multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. The spectra of the ligands and the AuNPs were collected in dimethyl sulfoxide-d6 (DMSO-d6).
The amount of PBH capped on the AuNPs was estimated by elemental analysis of C, H, N and S. Combustion analyses were performed on an EA 1180-Elemental Analyzer (Carlo Erba, Milan, Italy).
Fourier transform infrared spectroscopy
Fourier transform infrared (FT-IR) spectra in the range of 600 to 4,000 cm−1 were recorded using a Nicolet-550 FT-IR spectrophotometer (Thermo Fisher, Hudson, NH, USA). The analysis was done in the solid state. Thirty-two scans were used to record the IR spectra.
Ultraviolet–visible (UV–vis) spectroscopy measurements of the AuNP samples were recorded on a Cary-500 spectrophotometer (Agilent Tecnologies, Santa Clara CA, USA) within the range 300 to 900 nm. The samples were prepared, using water as solvent, at 100 μg/ml. UV–vis measurements were also taken after suspension of the AuNPs in EMEM/S+ and EMEM/S- at a concentration of 100 μg/ml and at time-point 0 and 2, 4 and 24 h after incubation at 37°C.
Dynamic light scattering
Dynamic light scattering (DLS) was used to determine the hydrodynamic size of NPs in solution, using a Zetasizer Nano-ZS (Malvern Instruments Ltd., Worcestershire, UK). Measurements of the hydrodynamic size of the NP suspensions (100 μg/ml) in Milli-Q water and in EMEM biological medium with serum (EMEM/S+) and without serum (EMEM/S-) were taken at time 0 and at 24 h under exposure conditions (37°C and 5% CO2). Careful attention was paid to distinguish measurements of background serum proteins from NP agglomerates in suspensions prepared in EMEM/S+. In addition, to study stability over time and the state of particles during the cell exposure timeframe in EMEM/S-, we conducted a kinetic study. DLS measurements were taken directly after the AuNPs were suspended (time 0) and at 2, 4, 24 and 48 h of incubation in exposure conditions. Three independent analyses were performed, and the mean ± standard deviation (SD) was used to represent results. Four measurements were taken in each independent analysis, with each measurement consisting of six runs, each lasting 10 s. The average from each of these measurements was calculated using Zetasizer series software 6.20 (Malvern Instrument). The instrument was set to automatically select the best conditions for measurements. A kinetic study was not performed in EMEM/S+ because of evidence of a stable suspension from time 0 to 24 h under exposure conditions when serum was present.
Zeta potential measurements were performed to determine the stability of the PBH-capped AuNPs in Milli-Q water and in the different medium suspensions (EMEM/S+ and EMEM/S-). A Malvern Zetasizer Nano-ZS and folded capillary cells (Malvern Instruments Ltd., Worcestershire, UK) were used. One-millilitre aliquots of AuNP suspensions (100 μg/ml) were taken directly after preparation and 24 h after incubation in the different media. Due to the limitations of high salt content in both medium suspensions, zeta potential measurements were performed only in Milli-Q water. Three independent measurements were taken, and the mean ± SD is presented.
Optical microscopy and visual sedimentation of AuNP suspensions
An inverted light microscope Axiovert 25 (Carl Zeiss, Madrid, Spain) equipped with a Canon EOS 1000D (Canon, Madrid, Spain) camera was used to take images. NP suspensions (0.781 to 100 μg/ml) were prepared in EMEM/S+ and EMEM/S- medium, and 100-μl aliquots of each concentration were suspended in 96-well plates. Suspensions were viewed 24 h after incubation in exposure conditions (37°C/5% CO2). A recent study carried out by Cho et al.  highlights the importance of considering sedimentation when carrying out NP toxicity studies in vitro. Those authors reported that different concentrations of NPs in the bottom of culture plates or ‘interaction zones’ caused by distinct ratios of sedimentation to diffusion velocities can result in variations in uptake. To detect differences in dispersion and sedimentation between the PBH-capped AuNPs in EMEM/S+ and EMEMS/S- medium, photographs were taken of the AuNP suspensions (100 μg/ml) in 1.5-ml tubes after 24-h incubation under exposure conditions.
Cell culture and AuNP exposure
Human liver hepatocellular carcinoma cells (Hep G2) were from the American Type Culture Collection (Manassas, VA, USA). These cells were cultured in EMEM medium supplemented with 10% FBS, 1% penicillin/streptomycin, 1% ultraglutamine and 1% NEAA. They were incubated at 37°C with 5% CO2 in a humidified incubator. For AuNP exposure, cells were plated at densities of 7.5 × 104 cells per millilitre in 96-well tissue culture microtiter plates (Greiner-Bio one, CellStar, Madrid, Spain) and subsequently incubated for 24 h. After this period, cells were exposed to a series of concentrations of the five AuNP preparations for either 2 or 24 h for ROS production studies or for 24 or 48 h for the cytotoxicity studies. AuNP suspensions were prepared in high-grade Milli-Q water to achieve a stock concentration of 1,000 μg/ml. All stock preparations were stored at 4°C. AuNP working concentrations were prepared from the 1,000 μg/ml stock preparations in EMEM/S + or EMEM/S-. Given the different size and stability profiles found for the AuNPs when suspended in these two types of medium, as shown by UV–vis, DLS and TEM analysis, we performed exposures in medium with and without serum. Working concentrations ranged from 0.781 to 100 μg/ml and were prepared using serial half dilutions. The final concentration of water in EMEM medium did not cause any osmotic imbalance. For each assay, three independent experiments were performed, with exposures carried out in triplicate for each concentration. Untreated cells in culture medium were used as negative controls in all experiments, while a serial half dilution of chloramine-T was used to produce a concentration range between 0.325 and 10 mmol/l, which was used as a positive control.
Interference of AuNPs in toxicity assays
NP suspensions of each concentration tested were prepared in EMEM medium, phosphate-buffered saline (PBS) and sulfosalicyclic acid dihydrate (SSA) 5% (w/v) or MEM phenol red-free medium, depending on the assay system being used, and included in the assay as another control to check possible AuNP absorbance at the corresponding wavelengths. Very high dose-dependent interferences were observed at the wavelengths used for the methyl thiazol tetrazolium (MTT) and neutral red uptake assay (NRU) assays. Some measurements were carried out after washing the cells to determine if this washing could lead to a reduction in the number of remaining AuNPs and consequently in the interference. We also examined whether the AuNPs used in this study interacted with glutathione. For that, a cell-free experiment was set up in which a constant concentration (8 μmol/l) of glutathione was incubated with a range of AuNP concentrations for 2 h. The glutathione content was then measured as described below.
Methyl thiazol tetrazolium and neutral red uptake assays
The MTT [(4,5-dimethylthiazoyl-2-yl)-2,5-diphenyltetrazolium bromide)] reduction assay, based on the conversion of tetrazolium salts to formazan crystals, was used to evaluate cell viability on the basis of mitochondrial activity, following the method described by Mosmann . The NRU assay was used to determine the accumulation of neutral red dye in the lysosomes of viable, uninjured cells . After the 24-h exposure, cells were incubated for 3 h with 500 μg/ml MTT reagent or for 2 h with 100 μg/ml neutral red dye, depending on the assay being performed. The resulting formazan crystals and remaining neutral red dye were dissolved with isopropanol or 1% glacial acetic acid in 50% ethanol, respectively. The absorbance of each well was read at 550 and 570 nm for the NRU and MTT assays, respectively, using a Tecan GENios plate reader (Tecan Group Ltd., Männedorf, Switzerland).
The method described by O’ Brien et al. , based on the reduction of resazurin to resorufin by mitochondrial oxidoreductases, was used. Cells were exposed to the AuNPs for 24 h, suspensions were removed, and cells washed with PBS and then treated with 20% (v/v) of resazurin dye reagent prepared in EMEM medium. The plate was then placed in a 37°C/5% CO2 incubator for 2 h, after which the fluorescence intensity was read at 532-nm excitation and 595-nm emission wavelengths using a Tecan GENios plate reader. Results are represented as a percentage of the control. To study whether there was any further reduction in viability, cytotoxicity was also analysed after 48 h of exposure.
Images of cell condition
At 2 and 24 h of exposure, images of the cells treated with NPs were taken and analysed for signs of cytotoxicity. An inverted light microscope (Axiovert 25, Carl Zeiss) equipped with a camera was used to take images. Evidence of cytoskeleton rounding or a change in normal shape compared to untreated controls was regarded as a sign of cytotoxicity. Also, to determine the degree of cytotoxicity, we compared the morphology of cultured cells with that of cells exposed to the positive control chloramine-T.
Quantification of reactive oxygen species
Intracellular ROS production was determined using the dichlorofluorescein (DCF) assay . Stock aliquots of 2’, 7’-dichlorofluorescein diacetate (DCFH-DA) were prepared in dimethyl sulfoxide (DMSO) (100 mM) and diluted 1:1,000 in MEM phenol red-free medium to a final concentration of 100 μM, 0.1% (v/v) DMSO. After the exposure period (2 or 24 h), the medium and exposure compounds were removed, and cells were washed with PBS. Next, 100 μM of DCFH-DA probe was added to each well. The plate was incubated at 37°C/5% CO2 in the dark for 30 min. After the incubation period, the DCFH-DA probe was removed, and the cells were washed twice with PBS. MEM phenol red-free medium was then added to the cells, and the fluorescence was measured at 485-nm excitation and 535-nm emissions (Tecan GENios plate reader). Fluorescent readings were taken immediately (time 0) and every 15 min over 60 min, with the plates maintained under dark conditions and incubated under exposure conditions (37°C/5% CO2) between measurements. ROS production was calculated as the percentage increase in fluorescence per well over a 60-min period using the formula [(Ft60 − Ft0)/Ft0 × 100], where Ft60 and Ft0 are the fluorescence measured at time 60 and 0 min, respectively. This result was finally expressed as percentage of the control.
Reduced glutathione/oxidised glutathione ratio
The assay protocol was set up based on the optimised microtiter plate method used by Allen et al. . Following the 24-h exposure, cells were lysed, and 50 μl of PBS was then added to each well. Twenty-five microlitres of cell suspension was transferred to a new 96-well plate and used to assay for protein content. To the other 25 μl of lysed cells, we added 50 μl of ice-cold 5% (w/v) SSA diluted in Milli-Q water in order to remove any interfering proteins from the sample. Of this suspension, 25 μl was used to assay for total glutathione (reduced glutathione + oxidised glutathione ratio - GSH + GSSG) content, while the other 25 μl was treated with 4-vinylpyridine 0.5 μmol/l, a scavenger of GSH, to assay the GSSG content. One hundred twenty-five microlitres of reaction buffer (PBS 143 mmol/l containing 6.3 mmol/l EDTA at pH 7.4, 229 U/ml GSH reductase, 2.39 mmol/l β-nicotinamide adenine dinucleotide phosphate (NADPH) and 0.01 mol/l 5, 5’-dithiobis (2-nitrobenzoic acid) (DTNB)) was added to each 25-μl suspension. The conversion of DTNB to 5’-thiol-2-nitrobenzoic acid (TNB) by the oxidation of GSH to GSSG was monitored by measuring absorbance at 405 nm every min over 10 min using a Tecan GENios plate reader. The rate of conversion, measured by the slope of the curve, was proportional to the concentration of glutathione in the sample. A standard curve with different concentrations of GSSG was used to calculate the glutathione contents in the samples.
For all the assays used, we performed three independent experiments with exposures carried out in triplicate for each concentration. The values shown are expressed as mean ± standard error of the mean (SEM). Sigma Plot 12 software (Systat Software Inc, CA, USA) was used for statistical analysis. The normality of the distribution was checked by means of the Shapiro-Wilk test. Equal variance was not assumed by the software and was tested (F test). A one-way repeated measures analysis of variance (RM-ANOVA) was carried out, followed by a post hoc Dunnett’s test with P < 0.05 or P < 0.01.
Physico-chemical characterisation of PBH-capped AuNPs
Structural characteristics of the AuNPs from elemental analysis and TEM data
Calculated m/nafrom %Nb
Number of Au atomsc
PBH units per Au nanoparticle
Au[(Gly-Tyr-TrCys) 2 B]
Physico-chemical characterisation of PBH-capped AuNPs under culture conditions
UV–vis absorption spectroscopy
Physico-chemical properties of PBH-capped AuNPs (100 μg/ml) under different conditions over time
148 ± 2
148 ± 1
−31.6 ± 2.0
242 ± 4
243 ± 6
233 ± 15
1,239 ± 26
Au[(Gly-Tyr-TrCys) 2 B]
143 ± 1
143 ± 1
−37 ± 1.4
261 ± 1
261 ± 2
251 ± 15
195 ± 2
591 ± 73
507 ± 65
−36 ± 1.1
987 ± 205
987 ± 207
407 ± 21
1,230 ± 8
161 ± 5
150 ± 12
203 ± 13
201 ± 9
229 ± 23
228 ± 10
−39 ± 1.1
190 ± 13
190 ± 4
1568 ± 28
1,368 ± 25
38 ± 6
40 ± 3
27 ± 9
28 ± 3
205 ± 1
205 ± 1
−43.2 ± 1.1
261 ± 3
260 ± 4
271 ± 23
908 ± 23
97 ± 3
Transmission electron microscopy
Optical microscopy and visual sedimentation of AuNP suspensions
Interference of AuNPs with toxicity assays
Methyl thiazol tetrazolium and neutral red uptake assays
The MTT and NRU assays could not be performed as there was AuNP interference at the wavelengths used in these tests (570 and 550 nm, respectively) (Figure 9a,b).
Cytotoxicity of PBH-capped AuNPs following 24- and 48-h exposure (EMEM/S-), using resazurin assay
Exposure concentration (μg/ml)
97 ± 1
97 ± 1*
96 ± 1*
94 ± 0.3** a
98 ± 1
98 ± 2
91 ± 1
69 ± 4** a
Measured interference (%)
96 ± 2
95 ± 2
94 ± 4
88 ± 4
Au[(Gly-Tyr-TrCys) 2 B]
98 ± 1
96 ± 1*
93 ± 1**
90 ± 1**
95 ± 2
100 ± 2
95 ± 3
87 ± 2*
Measured interference (%)
96 ± 3
90 ± 6
85 ± 7
76 ± 6
96 ± 1
96 ± 1*
96 ± 1*
91 ± 2** a
94 ± 1
91 ± 6*
81 ± 6**
71 ± 5** a
Measured interference (%)
95 ± 2
92 ± 2
90 ± 4
88 ± 4
97 ± 1
96 ± 0.4*
93 ± 0.4**
94 ± 2** a
97 ± 1
91* ± 3
88 ± 4**
68 ± 4 ** a
Measured interference (%)
93 ± 1
91 ± 2
89 ± 5
98 ± 1
97 ± 1
88 ± 1**
94 ± 4
93 ± 1
88 ± 2 **
77 ± 1**
Measured interference (%)
95 ± 1
91 ± 3
87 ± 4
Images of cell condition
Quantification of reactive oxygen species
Reduced glutathione/oxidised glutathione ratio
This assay could not be performed due to AuNP interference with the system (Figure 9d). There is a concentration-dependent decrease in the rate of conversion (slope) of DTNB to TNB caused by the interaction of the AuNPs with glutathione.
In this study, we have made some important observations concerning the biological behaviour of PBH-capped AuNPs. Depending on the structure of the PBH capping ligand, the behaviour of AuNPs differed both in terms of stability and biocompatibility. The PBH-capped AuNPs used in this study associated in different ways, forming agglomerates of different sizes under culture conditions, as demonstrated through DLS measurements, UV–vis analysis and optical imaging. The stability of these particles over time is dictated by both the structure of the PBH ligand and the surrounding medium. Even the smallest of changes in ligand structure can lead to great differences in AuNP behaviour. We detected clear differences in the hydrodynamic size of AuNPs in EMEM/S+ and EMEM/S-. In the former, all the AuNP preparations experienced a uniform increase in hydrodynamic size, possibly because of serum coating forming a corona, as proposed for other NPs [54, 55], but these preparations remained in a stable size distribution over 24 h. It would appear that the serum coating prevented further interaction between the individual AuNPs over time. In agreement with this finding, Ehrenberg et al.  demonstrated protein binding to polystyrene particles (100 nm) with COOH functional groups within seconds with stable protein-coated NPs after as little as 30 min and these NPs remained stable for the entire test period (4 h). According to our UV–vis and DLS analyses, all PBH-capped AuNPs form stable agglomerates under culture conditions when serum was present. However, considerations are needed when serum is not present. In this case, the structure of the PBH greatly influences the stability and biocompatibility of the AuNP. In EMEM/S-, the characteristic hydrodynamic size distribution profiles of all the NP preparations increased considerably in a time-dependent manner, with the exception of Au[(Gly-Tyr-TrCys)2B]. This PBH-capped AuNP had the same hydrodynamic size distribution profile range (150 to 260 nm) in EMEM/S- as in a water suspension and in medium containing serum. Thus, the hydrodynamic size decreased approximately 40 nm upon incubation. This reveals that the medium culture had less of an effect on the AuNPs Au[(Gly-Tyr-TrCys)2B]. Interestingly, sizes up to micron scale were recorded for Au[(Met)2B] (1,568 nm) almost immediately upon contact with the EMEM/S- medium. UV–vis analysis of this AuNP suspension over time revealed red shifts in the SPR band, with a slight broadening, suggesting agglomeration of NPs in that medium. For Au[(Gly-Trp-Met)2B], Au[(Gly-Tyr-Met)2B] and Au[(Met)2B], which contain methionine, a minimal decrease in the intensity band was observed over time, probably caused by the adsorption of amino acids of the culture medium. In contrast, in the UV–vis spectrum of Au[(Gly-Tyr-TrCys)2B], the decrease in the intensity of SPR band was not observed, suggesting that the steric bulk and the strong interaction of (Gly-Tyr-TrCys)2B with the gold prevents the adsorption of compounds from culture medium. Only after 24-h incubation, the UV–vis spectrum shows a shoulder in the range of 550 to 800 nm. It seems that the aggregation process occurs slower than in other samples. AuNP agglomeration and interaction with medium over time was also confirmed with TEM analysis.
Differences in the structure of the PBH capping agents used in this study led to distinct associations between individual AuNPs and their environment. The stability of Au[(Gly-Tyr-TrCys)2B] and Au[(Gly-Tyr-Met)2B] differed in cell culture conditions. This difference could be attributed to the stabilising effect of the TrCys group in comparison with the Met group. TrCys and Met residues are involved in binding to the gold surface. The higher binding of the PBH (Gly-Tyr-TrCys)2B to the gold in comparison with the PBH (Gly-Tyr-Met)2B is due to the additional aromatic interactions of the TrCys residue. The bulkier group, TrCys, may contribute to protecting individual NPs from assembling into larger agglomerates, thereby leading to the stability of Au[(Gly-Tyr-TrCys)2B] agglomerates. In addition, as revealed by elemental analysis, Au[(Gly-Tyr-TrCys)2B] was stabilised by 40 PBH units in comparison with 7 PBH units for Au[(Gly-Tyr-Met)2B]. Similar considerations can be made for Au[(TrCys)2B] and Au[(Met)2B]. Au[(TrCys)2B] was stable up to 4 h and formed smaller agglomerates over time compared to Au[(Met)2B]. The stabilisation of Au[(TrCys)2B] was achieved with 97 PBH units compared to 57 units for Au[(Met)2B]. It appears that the TrCys group also conferred stability upon Au[(TrCys)2B]. Overall, these findings suggest that the TrCys residue and the steric bulk of PBH (Gly-Tyr-TrCys)2B are responsible for the remarkable stability of Au[(Gly-Tyr-TrCys)2B] agglomerates.
The observations reported here have a major implication for the use of specific PBH capping agents in nanomaterial science. By applying PBH capping agents with different structures, the physico-chemical properties of AuNPs can be manipulated, thus affording tunability in diverse environments.
Interestingly, we observed that the two PBH-capped AuNPs that showed increased stability, namely Au[(Gly-Tyr-TrCys)2B] and Au[(TrCys)2B], also produced the highest increase in ROS levels. However, significant ROS production was detected only at the two highest doses (50 and 100 μg/ml), thus indicating the feasibility of use at lower concentrations. Oxidative stress induction has been proposed as the principal mechanism of toxicity for many forms of NPs [57–59], including AuNPs . Although the exact biological mechanism behind the action of the AuNPs was not determined in this study, we reveal that they all have the capacity to produce increased levels of ROS. However, the extent of this production differed depending on the PBH structures attached to the AuNP and the medium environment. ROS levels twofold higher than control levels were recorded after exposure to 100 μg/ml Au[(Gly-Tyr-TrCys)2B]. In contrast, exposure to the same concentration of Au[(Gly-Tyr-Met)2B] elicited only a slight increase in ROS production, which was 50% higher than control levels. The presence or absence of serum also influenced the oxidative stress response to the PBH-capped AuNPs. Those that caused the highest increase in ROS levels in EMEM/S- had a significantly attenuated capacity to induce ROS in the Hep G2 cells in EMEM/S+ medium. For instance, Au[(Gly-Tyr-TrCys)2B] AuNPs elicited the highest levels of ROS in EMEM/S-, and this effect was weakened in EMEM/S+, despite this NP having the same size distribution in both mediums (±10 nm). It could therefore be assumed that the attenuated ROS induction observed for all the NPs in EMEM/S+ is not related to size but specifically to serum coating. Merhi et al.  showed that endocytosis decreases when NPs are exposed to increasing concentrations of fetal calf serum and bovine serum albumin.
How the AuNPs interact with the cells or whether the different PBH capping agents influence the capacity of the particles to enter cells were not addressed extensively in this study. However, some observations and remarks can be made on the basis of our results. It is known that differently charged functional groups have different associations with cells. In this study, all zeta potentials were negative due to the presence of carboxylate (COO−) groups on the attached peptide-biphenyl coatings. Using silica NPs modified with amine and carboxyl functional groups and the murine macrophage cell line (RAW264.7), Nabeshi et al.  showed that while amine-functionalised silica NPs absorbed to the plasma membrane, carboxyl functionalities penetrated deeper intracellularly. This finding would suggest that these carboxyl groups bury themselves inside the cell membrane. Thus, the increased biological activity of Au[(Gly-Tyr-TrCys)2B] may be explained not only by its stability, remaining in individual AuNP agglomerates of approximately 200 nm in size but also by the presence of free carboxyl groups interacting with cellular components. In addition, studies show that the aromatic structures of tyrosine residues are important regulators of NP cellular uptake (referred to as the aromatic structure hypothesis) . According to these studies, the tyrosine residues in the PBH cap of Au[(Gly-Tyr-TrCys)2B] NPs might enhance the cellular uptake. Using Hep G2 cells, Yuan et al.  demonstrated that hydroxyapatite NPs as large as 175 nm are taken up by the cells but do not penetrate the nuclear membrane and are confined to the perinuclear region. However, Johnston et al. , who also studied the uptake and intracellular fate of NPs in Hep G2 cells, came to the conclusion that the internalisation of 200 nm negatively charged carboxylated polystyrene NPs was limited because of size.
If the PBH-capped AuNPs are taken up, their strong affinity for GSH, together with the significant increase in ROS production, as illustrated in this study, would suggest that the AuNPs act on the same mechanism of oxidative stress as that proposed by Gao et al. . These authors hypothesised that AuNP-induced oxidative stress in the HL7702 human liver cell line is related to the binding of these NPs to endogenous antioxidants (GSH), leading to complete depletion after 48 h. The increase in surface area associated with the decrease in size allows for more GSH binding and thus depletion. They also reported that the extent of oxidative stress depends on NP access to cytosolic GSH or mitochondrial GSH reserves. Hence, increased oxidative stress may occur with smaller NPs. This notion would explain the different levels of ROS production observed in this study, in particular the higher ROS levels elicited by Au[(Gly-Tyr-TrCys)2B] (the AuNPs present in the smallest hydrodynamic size, as shown by DLS).
Evidence of dark assemblies in Hep G2 cells exposed to AuNP Au[(Gly-Tyr-TrCys)2B] would suggest cellular interaction/internalisation; however, further studies are needed. Cells undergoing autophagy have clearly visible autophagosomes, which form around degraded cellular components. The dark assemblages present in Hep G2 cells after exposure to Au[(Gly-Tyr-TrCys)2B] resemble these autophagosomes. Li et al.  proposed a cell survival mechanism of autophagy upon exposure to AuNPs. This mechanism has been studied further by Ma et al. , who showed that AuNPs that are taken up and accumulate in lysosomes induce autophagosome accumulation through the blockage of the autophagy flux. This observation supports the findings in this study for Au[(Gly-Tyr-TrCys)2B]. In this case, despite the high levels of ROS produced, the cells did not succumb to the same loss in viability as that registered for the other NPs at 48 h of exposure. This phenomenon was observed only for cells exposed to the AuNP Au[(Gly-Tyr-TrCys)2B], thus suggesting that the unique state of this NP in the culture medium influences the NP-cell interaction.
In fact, AuNPs eliciting the lowest increase in ROS levels after 24 h also showed the greatest loss in viability after 48 h of incubation: exposure to Au[(Gly-Trp-Met)2B], Au[(Gly-Tyr-Met)2B] and Au[(Met)2B] reduced viability to 69%, 71% and 68%, respectively. These AuNPs all formed large agglomerates and had Met groups in their PBH-capping agents.
Several considerations need to be made when studying NP toxicity. One must be aware that NPs may interact unfavourably with assay components. The AuNPs described herein absorb at the same wavelength as those used for the MTT cytotoxicity assay (570 nm) and NRU assay (550 nm). NP interferences with commonly used toxicity assays, such as NRU and MTT, have been reported previously [69, 70]. In addition, AuNP interference was also observed when carrying out the GSH/GSSG ratio assay. Care should be taken when interpreting results in order to avoid false positive results. One should also consider that the physico-chemical state of the NP under distinct assay conditions may also lead to differences in levels of interference. All of these factors must not be overlooked.
Here, we prepared AuNPs using several PBHs as capping agents and studied the influence of the structure of these agents on the physico-chemical state and biocompatibility of the resulting NPs. All the AuNPs tested showed excellent dispersibility in water and form stable agglomerates under culture conditions when serum was present. One PBH-capped AuNP preparation, namely (Au[(Gly-Tyr-TrCys)2B]), showed unique physico-chemical properties presenting agglomerates (approximately 200 nm) that remained in the same size distribution under cell culture conditions as when suspended in water, even in the absence of serum. Interestingly, these AuNPs elicited the highest oxidative stress response, with evidence of a unique biological interaction that did not lead to a reduction in Hep G2 cell viability after 48 h of exposure. Our findings suggest that these particular PBH-capped AuNPs exerts a distinct effect on the Hep G2 cell line that is governed by their particular conformation, which is controlled by the chemical structure of their capping agent (Gly-Tyr-TrCys)2B. Given the distinct cellular morphology after exposure to these AuNPs and previous reports of AuNP mechanisms of interactions with biological systems, we propose that the Hep G2 cells undergo a cell survival mechanism of autophagy upon exposure to these AuNPs, thus supporting the notion of a cellular interaction/internalisation of these AuNPs. Given the relevance of interaction/internalisation, further research efforts should address the applicability of these AuNPs in drug delivery systems.
This research was performed under the Environmental ChemOinformatics (ECO) Marie Curie Initial Training Network (ITN) programme, funded by the Seventh Research Framework Programme (FP7) of the European Union (238701). We also thank Mapfre research grants 2010, the Spanish Ministry of Economy and Competitiveness (MINECO project CTQ 2010–19295) and the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (Project AT 2011–001) for financial support.
- Ghosh P, Han G, De M, Kim CK, Rotello VM: Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008, 60: 1307–1315. 10.1016/j.addr.2008.03.016View Article
- Dreaden EC, Mackey MA, Huang X, Kang B, El-Sayed MA: Beating cancer in multiple ways using nanogold. Chem Soc Rev 2011, 40: 3391–3404. 10.1039/c0cs00180eView Article
- De Long RK, Reynolds CM, Malcolm Y, Schaeffer A, Severs T, Wanekaya A: Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules. Nanotechnol Sci Appl 2010, 3: 53–63.View Article
- Parveen S, Misra R, Sahoo SK: Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed Nanotechnol 2012, 8: 147–166. 10.1016/j.nano.2011.05.016View Article
- Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, Olmedo I, Clos A, Sadagopa-Ramanujam VM, Urayama A, Vergara L, Kogan MJ, Soto C: Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Bioph Res Co 2010, 393: 649–655. 10.1016/j.bbrc.2010.02.046View Article
- Gu YJ, Cheng J, Lin CC, Lam YW, Cheng SH, Wong WT: Nuclear penetration of surface functionalized gold nanoparticles. Toxicol Appl Pharmacol 2009, 237: 196–204. 10.1016/j.taap.2009.03.009View Article
- Bai X, Ma H, Li X, Dong B, Zheng L: Patterns of gold nanoparticles formed at the air /water interface: effects of capping agents. Langmuir 2010, 26: 14970–14974. 10.1021/la102674fView Article
- Asharani PV, Lianwu Y, Gong Z, Valiyaveettil S: Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology 2011, 5: 43–54. 10.3109/17435390.2010.489207View Article
- Pérez Y, Mann E, Herradón B: Preparation and characterization of gold nanoparticles capped by peptide-biphenyl hybrids. J Colloid Interf Sci 2011, 359: 443–453. 10.1016/j.jcis.2011.04.029View Article
- Herradón B, Montero A, Mann E, Maestro MA: Crystallization-induced dynamic resolution and analysis of the noncovalent interactions in the crystal packing of peptide–biphenyl hybrids. Cryst Eng Commun 2004, 6: 512–521. 10.1039/b406652aView Article
- Mann E, Montero A, Maestro MA, Herradón B: Synthesis and crystal structure of peptide-2, 2-biphenyl hybrids. Helv Chim Acta 2002, 85: 3624–3638. 10.1002/1522-2675(200211)85:11<3624::AID-HLCA3624>3.0.CO;2-YView Article
- Montero A, Alonso M, Benito E, Chana A, Mann E, Navas JM, Herradón B: Studies on aromatic compounds: inhibition of calpain I by biphenyl derivatives and peptide-biphenyl hybrids. Bioorg Med Chem Lett 2004, 14: 2753–2757. 10.1016/j.bmcl.2004.03.071View Article
- Bendová L, Jureka P, Hobza P, Vondrášek J: Model of peptide bond-aromatic ring interaction: correlated ab initio quantum chemical study. J Phys Chem B 2007, 111: 9975–9979. 10.1021/jp072859+View Article
- Nishio M, Umezawa Y, Honda K, Tsuboyama S, Suezawa H: CH/π hydrogen bonds in organic and organometallic chemistry. Cryst Eng Commun 2009, 11: 1757–1788. 10.1039/b902318fView Article
- Heaton MJ, Bello P, Herradón B, Campo A, Jimenez-Barbero J: NMR study of intramolecular interactions between aromatic groups: Van der Waals charge-transfer, or quadrupolar interactions? J Am Chem Soc 1998, 120: 12371–12384. 10.1021/ja985529zView Article
- Ranganathan D, Haridas V, Gilardi R, Karle IL: Self-assembling aromatic-bridged serine-based cyclodepsipeptides (serinophanes): a demonstration of tubular structures formed through aromatic π − π interactions. J Am Chem Soc 1998, 120: 10793–10800. 10.1021/ja982244dView Article
- Mann E, Rebek JJ: Deepened chiral cavitands. Tetrahedron 2008, 64: 8484–8487. 10.1016/j.tet.2008.05.136View Article
- Lévy R, Thanh NT, Doty RC, Hussain I, Nichols RJ, Schiffrin DJ, Brust M, Fernig DG: Rational and combinatorial design of peptide capping ligands for gold nanoparticles. J Am Chem Soc 2004, 126: 10076–10084. 10.1021/ja0487269View Article
- Jiang J, Oberdörster G, Biswas P: Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 2009, 11: 77–89. 10.1007/s11051-008-9446-4View Article
- Warheit DB: How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 2008, 101: 183–185. 10.1093/toxsci/kfm279View Article
- Nel A, Xia T, Mädler L, Li N: Toxic potential of materials at the nano level. Science 2006, 311: 622–627. 10.1126/science.1114397View Article
- Studer AM, Limbach LK, Duc LV, Krumeich F, Athanassiou EK, Gerber LC, Moch H, Stark WJ: Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. Toxicol Lett 2010, 197: 169–174. 10.1016/j.toxlet.2010.05.012View Article
- Auffan M, Rose J, Wiesner MR, Bottero JY: Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro . Environ Pollut 2009, 157: 1127–1133. 10.1016/j.envpol.2008.10.002View Article
- Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W: Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3: 1941–1949. 10.1002/smll.200700378View Article
- Li Y, Sun L, Jin M, Du Z, Liu X, Guo C, Li Y, Huang P, Sun Z: Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells. Toxicol In Vitro 2011, 25: 1343–1352. 10.1016/j.tiv.2011.05.003View Article
- Liu Y, Meyer-Zaika W, Franzka F, Schmid G, Tsoli M, Kuhn H: Gold-cluster degradation by the transition of B-DNA into A-DNA and the formation of nanowires. Angew Chem Int Ed 2003, 42: 2853–2857. 10.1002/anie.200250235View Article
- Tsoli M, Kuhn H, Brandau W, Esche H, Schmid G: Cellular uptake and toxicity of Au55 clusters. Small 2005, 1: 841–844. 10.1002/smll.200500104View Article
- Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, Brandau W, Simon U, Jahnen-Dechent W: Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 2009, 5: 2067–2076. 10.1002/smll.200900466View Article
- Li T, Albee B, Alemayehu M, Diaz R, Ingham L, Kamal S, Rodriguez M, Bishnoi SW: Comparative toxicity study of Ag, Au, and Ag–Au bimetallic nanoparticles on Daphnia magna . Anal Bioanal Chem 2010, 398: 689–700. 10.1007/s00216-010-3915-1View Article
- Farkas J, Christian P, Urrea JAG, Roos N, Hassellöv M, Tollefsen KE, Thomas KV: Effects of silver and gold nanoparticles on rainbow trout ( Oncorhynchus mykiss ) hepatocytes. Aquat Toxicol 2010, 96: 44–52. 10.1016/j.aquatox.2009.09.016View Article
- Patra HK, Banerjee S, Chaudhuri U, Lahiri P, Dasgupta AK: Cell selective response to gold nanoparticles. Nanomed Nanotechnol 2007, 3: 111–119. 10.1016/j.nano.2007.03.005View Article
- Ponti J, Colognato R, Franchini F, Gioria S, Simonelli F, Abbas K, Uboldi C, Kirkpatrick CJ, Holzwarth U, Rossi F: A quantitative in vitro approach to study the intracellular fate of gold nanoparticles: from synthesis to cytotoxicity. Nanotoxicology 2009, 3: 296–306. 10.3109/17435390903056384View Article
- Li JJ, Lo SL, Ng CT, Gurung LR, Hartono D, Hande PM, Ong CN, Bay BH, Yung LLY: Genomic instability of gold nanoparticle treated human lung fibroblast cells. Biomaterials 2011, 32: 5515–5523. 10.1016/j.biomaterials.2011.04.023View Article
- Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schäffler M, Takenaka S, Möller W, Schmid G, Simon U, Kreyling WG: Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 2011, 77: 407–416. 10.1016/j.ejpb.2010.12.029View Article
- Wang L, Li YF, Zhou L, Liu Y, Meng L, Zhang K, Wu X, Zhang L, Li B, Chen C: Characterization of gold nanorods in vivo by integrated analytical techniques: their uptake, retention, and chemical forms. Anal Bioanal Chem 2010, 396: 1105–1114. 10.1007/s00216-009-3302-yView Article
- Kroll A, Pillukat MH, Hahn D, Schnekenburger J: Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm 2009, 72: 370–377. 10.1016/j.ejpb.2008.08.009View Article
- Kang KA, Wang J, Jasinski JB, Achilefu S: Fluorescence manipulation by gold nanoparticles: from complete quenching to extensive enhancement. J Nanobiotechnology 2011, 9: 1–13. 10.1186/1477-3155-9-1View Article
- Stobiecka M, Coopersmith K, Hepel M: Resonance elastic light scattering (RELS) spectroscopy of fast non-Langmuirian ligand-exchange in glutathione-induced gold nanoparticle assembly. J Colloid Interface Sci 2010, 350: 168–177. 10.1016/j.jcis.2010.06.010View Article
- Jadzinsky PD, Calero G, Ackerson CJ, Bushnell DA, Kornberg RD: Structure of a thiol monolayer-protected gold nanoparticle at 1.1 Å resolution. Science 2007, 318: 430–433. 10.1126/science.1148624View Article
- Cho CE, Zhang Q, Xia Y: The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol 2011, 6: 385–391. 10.1038/nnano.2011.58View Article
- Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65: 55–63. 10.1016/0022-1759(83)90303-4View Article
- Borenfreund E, Puerner JA: Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985, 24: 119–124. 10.1016/0378-4274(85)90046-3View Article
- O’Brien J, Wilson I, Orton T, Pognan F: Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000, 267: 5421–5426. 10.1046/j.1432-1327.2000.01606.xView Article
- Wang H, Joseph AJ: Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Bio Med 1999, 27: 612–616. 10.1016/S0891-5849(99)00107-0View Article
- Allen S, Shea JM, Felmet T, Gadra J, Dehn PF: A kinetic microassay for glutathione in cells plated on 96-well microtiter plates. Methods Cell Sci 2001, 22: 305–312.View Article
- Krpetic Z, Nativo P, Porta F, Brust M: A multidentate peptide for stabilization and facile bioconjugation of gold nanoparticles. Bioconjug Chem 2009, 20: 619–624. 10.1021/bc8003028View Article
- Liu X, Atwater M, Wang J, Huo Q: Extinction coefficient of gold nanoparticles with different sizes and different capping ligands. Colloids Surf B 2007, 58: 3–7. 10.1016/j.colsurfb.2006.08.005View Article
- Si S, Dinda E, Mandal TK: In situ synthesis of gold and silver nanoparticles by using redox-active amphiphiles and their phase transfer to organic solvents. Chem Eur J 2007, 13: 9850–9861. 10.1002/chem.200701014View Article
- Lyon JL, Fleming DA, Stone MB, Schiffer P, Williams ME: Synthesis of Fe oxide core/Au shell nanoparticles by iterative hydroxylamine seeding. Nano Lett 2004, 4: 719–723. 10.1021/nl035253fView Article
- Murphy CJ, Gole AM, Hunyadi SE, Stone JW, Sisco PN, Alkilany A, Kinard BE, Hankins P: Chemical sensing and imaging with metallic nanorods. Chem Commun 2008, 5: 544–557.View Article
- Zhang XD, Wu D, Shen X, Liu PX, Fan FY, Fan SJ: In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials 2012, 33: 4628–4638. 10.1016/j.biomaterials.2012.03.020View Article
- Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA: The nanoparticle–protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci 2007, 134–135: 167–174.View Article
- Alkilany AM, Murphy C: Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 2010, 12: 2313–2333. 10.1007/s11051-010-9911-8View Article
- Zhu Y, Li W, Li Q, Li Y, Li Y, Zhang X, Huang Q: Effects of serum proteins on intracellular uptake and cytotoxicity of carbon nanoparticles. Carbon 2009, 47: 1351–1358. 10.1016/j.carbon.2009.01.026View Article
- Allouni ZE, Cimpan MR, Høl PJ, Skodvin T, Gjerdet NR: Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium. Colloids Surf B Biointerfaces 2009, 68: 83–87. 10.1016/j.colsurfb.2008.09.014View Article
- Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdörster G, McGrath JL: The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 2009, 30: 603–610. 10.1016/j.biomaterials.2008.09.050View Article
- Møller P, Jacobsen RN, Folkmann KJ, Danielsen HP, Mikkelsen L, Hemmingsen GJ, Vesterdal KL, Forchhammer L, Wallin H, Loft S: Role of oxidative damage in toxicity of particulates. Free Radical Res 2010, 44: 1–46. 10.3109/10715760903300691View Article
- Choi EJ, Kima S, Ahna HJ, Youna P, Kangb SJ, Park K, Yid J, Ryua DY: Induction of oxidative stress and apoptosis by silver nanoparticles in the liver of adult zebrafish. Aquat Toxicol 2010, 100: 151–159. 10.1016/j.aquatox.2009.12.012View Article
- Stone V, Shaw J, Brown MD, Macnee W, Faux PS, Donaldson K: The role of oxidative stress in the prolonged inhibitory effect of ultrafine carbon black on epithelial cell function. Toxicol In Vitro 1998, 12: 649–659. 10.1016/S0887-2333(98)00050-2View Article
- Tedesco S, Doyle H, Blasco J, Redmond G, Sheehan D: Exposure of the blue mussel, Mytilus edulis , to gold nanoparticles and the pro-oxidant menadione. Comp Biochem Physiol C 2010, 151: 167–174.
- Merhi M, Dombu CY, Brient A, Chang J, Platel A, Le Curieux F, Marzin D, Nesslany F, Betbeder D: Study of serum interaction with a cationic nanoparticle: implications for in vitro endocytosis, cytotoxicity and genotoxicity. Int J Pharmaceut 2012, 423: 37–44. 10.1016/j.ijpharm.2011.07.014View Article
- Nabeshi H, Yoshikawa T, Arimori A, Yoshida T, Tochigi S, Hirai T, Akase T, Nagano K, Abe Y, Kamada H, Tsunoda SI, Itoh N, Yoshioka Y, Tsutsumi Y: Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages. Nanoscale Res Lett 2011, 6: 1–6.
- Yang Y, Fung SY, Liu M: Programming the cellular uptake of physiologically stable peptide-gold nanoparticles hybrids with single amino acids. Angew Chem Int Ed 2011, 50: 9643–9643. 10.1002/anie.201102911View Article
- Yuan Y, Liu C, Qian J, Wang J, Zhang Y: Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells. Biomaterials 2010, 31: 730–740. 10.1016/j.biomaterials.2009.09.088View Article
- Johnston JH, Semmler-Behnke M, Brown MB, Kreyling W: Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro . Toxicol Appl Pharmacol 2010, 242: 66–78. 10.1016/j.taap.2009.09.015View Article
- Gao W, Xu K, Ji L, Tang B: Effect of gold nanoparticles on glutathione depletion-induced hydrogen peroxide generation and apoptosis in HL7702 cells. Toxicol Lett 2011, 205: 86–95. 10.1016/j.toxlet.2011.05.1018View Article
- Li JJ, Hartono D, Ong CN, Bay BH, Yung LLY: Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 2010, 31: 5996–6003. 10.1016/j.biomaterials.2010.04.014View Article
- Ma X, Wu Y, Jin S, Tian Y, Zhang X, Zhao Y, Yu L, Liang XJ: Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano 2011, 5: 8629–8639. 10.1021/nn202155yView Article
- Belyanskaya L, Manser P, Spohn P, Bruinink A, Wick P: The reliability and limits of the MTT reduction assay for carbon nanotubes–cell interaction. Carbon 2007, 45: 2643–2648. 10.1016/j.carbon.2007.08.010View Article
- Ciofani G, Danti S, D’Alessandro D, Moscato S, Menciassi A: Assessing cytotoxicity of boron nitride nanotubes: interference with the MTT assay. Biochem Biophys Res Commun 2010, 394: 405–411. 10.1016/j.bbrc.2010.03.035View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.